N10,N11-di-alkylamine indolo[3,2-b]quinolines as hemozoin inhibitors: Design, synthesis and antiplasmodial activity
- 1 April 2015
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 23 (7) , 1530-1539
Abstract
No abstract availableKeywords
Funding Information
- Fundação para a Ciência e Tecnologia (FCT) (PTDC/SAU-FAR/114864/2009, PEst-OE/SAU/UI4013/2014)
- FCT (SFRH/BPD/72903/2010, SFRH/BD/80162/2011)
- National Research Foundation (NRF)
- South African Medical Research Council (SAMRC)
- University of Capetown
This publication has 26 references indexed in Scilit:
- Antimalarial Drug Discovery: From Quinine to the Dream of EradicationACS Medicinal Chemistry Letters, 2013
- Quinoline Drug–Heme Interactions and Implications for Antimalarial Cytostatic versus Cytocidal ActivitiesJournal of Medicinal Chemistry, 2013
- Insights into the Role of Heme in the Mechanism of Action of AntimalarialsACS Chemical Biology, 2012
- The numbers gameNature, 2012
- The Threat of Artemisinin-Resistant MalariaNew England Journal of Medicine, 2011
- Incorporation of Basic Side Chains into Cryptolepine Scaffold: Structure−Antimalarial Activity Relationships and Mechanistic StudiesJournal of Medicinal Chemistry, 2011
- Improved Traditional Phytomedicines in Current Use for the Clinical Treatment of MalariaPlanta Medica, 2011
- Indoloquinolines as Scaffolds for Drug DiscoveryCurrent Medicinal Chemistry, 2010
- Cryptolepine analogues containing basic aminoalkyl side-chains at C-11: Synthesis, antiplasmodial activity, and cytotoxicityBioorganic & Medicinal Chemistry Letters, 2008
- Structure−Function Relationships in Aminoquinolines: Effect of Amino and Chloro Groups on Quinoline−Hematin Complex Formation, Inhibition of β-Hematin Formation, and Antiplasmodial ActivityJournal of Medicinal Chemistry, 1999